Back

GLP1 agonists for obesity and diabetes.

3 December 2022 (13:00 - 13:20)
Organised by:
Congress Presentation Part of: Frontiers in cardiometabolic disease European Society of Cardiology ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Professor Junya Ako

Kitasato University School of Medicine, Sagamihara (Japan)

2 More presentations in this session

Presentation thumbnail
Lp(a) potential for treatment.
Professor S. Nicholls (Melbourne, AU)
Video
Presentation thumbnail
APSC Consensus statement on lipid management.
Doctor N. Koh (Singapore, SG)
Video

Access the full session

Session thumbnail
Frontiers in cardiometabolic disease
Video

The Event

Event poster

ESC Asia 2022 with APSC & AFC

3 December 2022 13:00 CET
You may be interested in
thumbnail
Congress Presentation
GLP-1 receptor agonists as an opportunity for patients with atherosclerotic cardiovascular disease as well as obesity in Germany
1 September 2025
thumbnail
Congress Presentation
Global cardiovascular health challenges - discussion
1 September 2025
thumbnail
Congress Presentation
Comparative analysis of monthly weight-regain dynamics after discontinuation of semaglutide vs tirzepatide
29 August 2026
thumbnail
Congress Presentation
Glucagon like peptide-1 receptor agonists and their combination with sodium-glucose cotransporter-2 inhibitors improve myocardial deformation and work index in type-2 diabetes after 12-month treatment
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources